Bio-Works reports that its prepacked OptioBio 40S and 40Q ion exchange columns deliver more than 30% higher dynamic binding capacity than GE Healthcare's HiScreen Capto SP and Q ImpRes columns at 10% breakthrough, with better cation-exchange resolution and equal anion-exchange resolution. All data…
Bioprocess developers choosing between prepacked Bio-Works OptioBio 40S and 40Q ion exchange columns and GE Healthcare's HiScreen Capto SP and Q ImpRes columns have one head-to-head dataset to work from, and it was generated by Bio-Works on its own products. It reports more than 30% higher dynamic binding capacity for both OptioBio columns at 10% breakthrough with bovine serum albumin, better cation-exchange resolution for the 40S column, and equal, not better, anion-exchange resolution for the 40Q column. No independent, peer-reviewed replication of these numbers exists.
A technical article dated June 3, 2025, written by Bio-Works scientists Kajsa Eriksson, Anna Heijbel, and Lars Haneskog, compares the two product lines at small scale. Bio-Works is a chromatography resin manufacturer based in Uppsala, Sweden. GE Healthcare manufactured the comparison columns.
The OptioBio columns tested are the 10x100 format: 10 mm inner diameter, 100 mm bed height, and 7.9 ml bed volume, prepacked in glass and ready for immediate use. The 40S resin carries sulfonate ligands and is a strong cation exchanger. The 40Q resin carries quaternary amine ligands and is a strong anion exchanger. Both are part of the WorkBeads 40 resin family, which Bio-Works sells as prepacked small columns and as bulk resin for larger industrial columns.
| Property | OptioBio 40S | OptioBio 40Q |
|---|---|---|
| Ligand | Sulfonate strong cation exchange | Quaternary amine strong anion exchange |
| Column format | 10x100 | 10x100 |
| Inner diameter | 10 mm | 10 mm |
| Bed height | 100 mm | 100 mm |
| Bed volume | 7.9 ml | 7.9 ml |
| Comparison column | HiScreen Capto SP ImpRes | HiScreen Capto Q ImpRes |
The reported results split cleanly between the two chemistries. On dynamic binding capacity, the vendor reports more than 30% higher capacity for each OptioBio column relative to the matching HiScreen Capto ImpRes column, measured at the QB10% breakthrough point. On resolution, the vendor reports significantly higher selectivity and improved resolution for the OptioBio 40S column on a four-protein mixture, while the OptioBio 40Q column is described as providing resolution equal to the HiScreen Capto Q ImpRes column. The word "significantly" is the vendor's description; no statistical analysis accompanies it.
That asymmetry is the first thing a buyer should notice. A capacity advantage is claimed for both resins, but a resolution advantage is claimed only for the cation exchanger. If an anion-exchange polishing step is the bottleneck, this dataset offers no reason to expect better separation from the 40Q column.
The article also states that the resins enable high-resolution separation with low backpressure and suit both capture and polishing. The low-backpressure claim is qualitative and no measured backpressure data are presented. The article describes the chromatograms but does not reproduce them, so the separations cannot be inspected directly. A product literature code PS55410011 AA printed on the article and an embedded 4:11 video mark the document as sales material rather than a scientific report.
Ion exchange chromatography separates biomolecules by net surface charge. A cation exchanger presents negatively charged ligands and binds molecules that carry a net positive charge in the running buffer. An anion exchanger presents positively charged ligands and binds molecules with a net negative charge. The WorkBeads 40S and 40Q resins are strong exchangers. Their sulfonate and quaternary amine groups remain fully ionized across the pH range used in protein purification, so the buffer pH can be chosen for protein stability and selectivity rather than to keep the ligand charged.
The resolution tests elute bound proteins with a salt gradient. As sodium chloride concentration rises, salt ions compete with bound proteins for the charged sites on the resin. Proteins with different net charges and charge distributions bind with different strengths and are displaced at different salt concentrations. The cation test uses a linear gradient from 0 to 50% elution buffer over 20 column volumes; the anion test uses 0 to 40% over 20 column volumes. The elution buffers in both tests contain 1 M NaCl.
Dynamic binding capacity is a kinetic property, not an equilibrium one. It is the amount of protein a column binds during loading at flow, and it is measured by watching the protein concentration in the effluent rise as the column approaches saturation. The QB10% criterion fixes the loading endpoint as the point at which the effluent concentration reaches 10% of the feed concentration. DBC depends on residence time, mass transfer, protein size, and buffer composition, so any DBC number is meaningful only with its conditions attached. A static capacity measured at equilibrium is always higher and is not the number used for process design.
Bovine serum albumin BSA serves as the model protein in the capacity tests, and the buffer pH is chosen to set its charge. At pH 4.0, below its isoelectric point, BSA is positively charged and binds to the sulfonate cation exchanger. At pH 8.0, above its isoelectric point, it is negatively charged and binds to the quaternary amine anion exchanger. The resolution runs use a residence time of 4 minutes at a linear flow rate of 150 cm/h. On the OptioBio 10x100 columns, 150 cm/h corresponds to 2.0 ml/min; on the smaller HiScreen columns it corresponds to 1.2 ml/min. The volumetric flows differ because the formats have different bed volumes, not because the linear velocities differ.
The capacity comparisons apply the same logic to both resin types: a single model protein, a single flow rate, and a single breakthrough criterion.
| Parameter | Cation exchange test | Anion exchange test |
|---|---|---|
| Columns compared | OptioBio 40S vs HiScreen Capto SP ImpRes | OptioBio 40Q vs HiScreen Capto Q ImpRes |
| Model protein | BSA, 2 mg/ml | BSA, 1 mg/ml |
| Binding buffer | 20 mM sodium citrate, pH 4.0 | 50 mM Tris-HCl, 50 mM NaCl, pH 8.0 |
| Linear flow rate | 150 cm/h | 150 cm/h |
| Breakthrough criterion | QB10% | QB10% |
| Reported result | 30% higher for OptioBio 40S | 30% higher for OptioBio 40Q |
The reported result in both rows is a capacity advantage of more than 30% for the OptioBio column. The BSA concentration and buffer differ between the tests because the two resins bind opposite charges; the protein concentration in the feed is part of the loading condition, not a property of the resin. The resolution comparisons use defined protein mixtures, and the conditions are shown below.
| Parameter | Cation exchange test | Anion exchange test |
|---|---|---|
| Columns compared | OptioBio 40S vs HiScreen Capto SP ImpRes | OptioBio 40Q vs HiScreen Capto Q ImpRes |
| Sample proteins | Concanavalin A, alpha-chymotrypsinogen A, ribonuclease A, lysozyme | Apo-transferrin, alpha-lactalbumin, soybean trypsin inhibitor |
| Binding buffer | 50 mM MES, pH 6.0 | 50 mM Tris-HCl, pH 7.4 |
| Elution buffer | 50 mM MES, 1 M NaCl, pH 6.0 | 50 mM Tris-HCl, 1 M NaCl, pH 7.4 |
| Gradient | 0-50% over 20 column volumes | 0-40% over 20 column volumes |
| Linear flow rate | 150 cm/h | 150 cm/h |
| Residence time | 4 minutes | 4 minutes |
| Volumetric flow, OptioBio | 2.0 ml/min | 2.0 ml/min |
| Volumetric flow, HiScreen | 1.2 ml/min | 1.2 ml/min |
| Sample load volume, OptioBio | 2.5 ml | 10 ml |
| Sample load volume, HiScreen | 1.5 ml | 6 ml |
| Reported result | Better selectivity and resolution for 40S | Equal resolution for 40Q |
The sample compositions carry the protein concentrations used in each run.
| Protein | Concentration | Test |
|---|---|---|
| Concanavalin A | 1.5 mg/ml | Cation |
| Alpha-chymotrypsinogen A | 0.5 mg/ml | Cation |
| Ribonuclease A | 1.5 mg/ml | Cation |
| Lysozyme | 0.5 mg/ml | Cation |
| Apo-transferrin | 0.7 mg/ml | Anion |
| Alpha-lactalbumin | 0.45 mg/ml | Anion |
| Soybean trypsin inhibitor | 1.4 mg/ml | Anion |
The sample volumes were scaled to the column volumes: the OptioBio 40S column received 2.5 ml of sample and the HiScreen SP column received 1.5 ml; the OptioBio 40Q column received 10 ml and the HiScreen Q column received 6 ml. That keeps the load per millilitre of resin comparable, which is the correct way to compare columns of different volumes. Loading more protein per millilitre on one column would distort both resolution and apparent capacity. The vendor states the same requirement: for a valid comparison, sample load per ml of resin and linear flow rate must be held constant, as they were here.
The buffer choices reflect typical operating conditions for each resin. The cation test binds at 50 mM MES, pH 6.0, and elutes with 50 mM MES, 1 M NaCl, pH 6.0. The anion test binds at 50 mM Tris-HCl, pH 7.4, and elutes with 50 mM Tris-HCl, 1 M NaCl, pH 7.4. At pH 6.0 the four cation-test proteins carry different positive charges and bind to the sulfonate resin with different affinities, so they elute in a salt gradient according to binding strength. At pH 7.4 the three anion-test proteins are negatively charged and behave the same way on the quaternary amine resin.
Because the same WorkBeads resins are available for larger industrial columns, the stated design intent is that conditions developed on the 10x100 prepacked format transfer to larger scale. The manufacturer lists proteins, peptides, and nucleic acids as intended applications for the resins, which separate these molecules by exploiting differences in surface charge.
Read carefully, the dataset establishes exactly three things. First, under the specified conditions, both OptioBio columns showed higher dynamic binding capacity than the HiScreen Capto ImpRes columns, and the difference was more than 30%. Second, the OptioBio 40S column separated the four-protein cation mixture with better selectivity and resolution than the HiScreen SP column. Third, the OptioBio 40Q column matched the HiScreen Q column on the three-protein anion mixture but did not exceed it.
What the dataset does not establish is just as important. The capacity claim is specific to BSA, to a single flow rate of 150 cm/h, and to the QB10% endpoint. BSA is a well-behaved model protein. Process feedstocks contain host cell proteins, DNA, lipids, aggregates, and product variants, and they may carry salts and excipients from upstream steps. A capacity ranking measured with BSA does not necessarily survive contact with a real feedstock. The more than 30% figure is also a single number with no replicate data, error range, or lot-to-lot information reported, so the precision of the comparison cannot be assessed.
The resolution comparison covers one competitor's columns. No other commercially available strong cation or anion exchange media were tested, so the results say nothing about how the OptioBio columns rank against the broader market. The run-to-run and lot-to-lot reproducibility of the prepacked columns is not addressed. The intended applications in peptides and nucleic acids are named but not tested. The claim that the resins give low backpressure and work for both capture and polishing is offered without measured backpressure data or examples at capture-scale loads.
The provenance of the data is a limitation. All results were generated by the manufacturer in its own testing, published through its own channel, and written by its own employees. That does not make the results false, but it means the comparison has not been subjected to independent review or replication, and the underlying chromatograms were not made available in the article.
No indexed, peer-reviewed study directly benchmarks the OptioBio columns against the HiScreen Capto ImpRes columns. The published benchmarking literature that does exist concerns other methods, but it is directly relevant to how a reader should weigh the vendor's claims, because it shows how much performance comparisons depend on test sets, metrics, and conditions.
A benchmarking study of AlphaFold2 on 588 peptide structures found that the predictor handled alpha-helical, beta-hairpin, and disulfide-rich peptides accurately, yet struggled with backbone Phi/Psi angles and disulfide bond patterns, and its confidence scores did not rank the lowest-RMSD structures best PMID 36525975 . The lesson for column benchmarking: a method can be strong on one property and weak on another. A vendor measurement of capacity on one protein at one flow rate is the column equivalent of reporting a single success metric while leaving the failure modes unmeasured.
A second study benchmarked the PANDORA v2.0 modelling software on 136 peptide-MHC class II complexes and reported quantitative error distributions: median backbone ligand root-mean-square deviations of 0.42 Å for the binding core and 0.88 Å for the whole peptide PMID 38143769 . The value of that claim rests on the dataset being fixed and sized and the error being reported completely. Applying the same standard to the column comparison exposes what is missing: base capacity numbers for each column, replicate counts, and any measure of run-to-run spread around the more than 30% figure.
A chemoproteomics study tested five cleavable biotin tags across three workflows and found that performance depended on the workflow; the acid-cleavable dialkoxydiphenylsilane tag in the protein-click, peptide-capture workflow gave the best enrichment efficiency, identification yield, and reproducibility PMID 35467356 . The winning tag under one set of conditions was not the universal winner. The same point applies to chromatography media: the ranking found in one buffer, on one protein, at one flow rate is a single working point, not a settled answer.
None of these studies tests an ion exchange resin. What they establish for this comparison is methodological, and it is decisive: single-condition, single-competitor, vendor-generated results are a starting point for evaluation, not a conclusion. Whether the OptioBio advantage generalizes to other proteins, real feedstocks, peptides, nucleic acids, or other flow rates remains unknown.
Researchers and buyers should treat the vendor data as a hypothesis to test, not a result to rely on.
Several questions remain open, and buyers should be direct in asking about them. How do the OptioBio columns perform against ion exchange media from other manufacturers beyond GE Healthcare's HiScreen line? Does the dynamic binding capacity advantage hold at flow rates other than 150 cm/h, at breakthrough endpoints other than QB10%, and with real process feedstocks? What do the columns do with peptides and nucleic acids, which are stated intended applications but are not tested in the article? What is the run-to-run and lot-to-lot reproducibility of the prepacked columns? What larger formats are available, and what evidence exists that conditions transfer from the 10x100 glass columns to them? And what is the actual backpressure versus flow-rate behavior, a claim made qualitatively but never measured in the source document?
Until those questions are answered with data that can be inspected, the accurate summary of this comparison is short: the available evidence, all of it from the manufacturer, shows a capacity advantage for both OptioBio columns and a resolution advantage for the 40S cation column under one defined set of conditions. Independent confirmation is absent, and that absence should shape the weight a buyer gives to the claims.
Vendors referenced: In Peptides.
Related reading: Combination peptide therapy may reduce opioid side effects, CAPA tracks biotherapeutic cell uptake and organelle distribution, Desalting and Buffer Exchange of Proteins with BabyBio Dsalt Columns, Cyclic Hexapeptide Mimics Disrupt HIV-1 Integrase and LEDGF/p75.